Eli Lilly Stock-Based Compensation — Historical Data
Eli Lilly (LLY) stock-based compensation was $626M in FY2025 (-3% YoY). The tables below show the complete quarterly and annual stock-based compensation history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Stock-Based Compensation
Fiscal Year
Stock-Based Compensation
YoY
2025
$626M
-3%
2024
$646M
+3%
2023
$629M
+69%
2022
$371M
+8%
2021
$343M
+11%
2020
$308M
+0%
2019
$307M
+21%
2018
$254M
-1%
2017
$256M
+0%
2016
$255M
+17%
2015
$218M
+40%
2014
$156M
+8%
2013
$145M
+2%
2012
$142M
-4%
2011
$147M
-36%
2010
$231M
-37%
2009
$368M
+44%
2008
$255M
+191%
2007
-$282M
Recent Quarterly Stock-Based Compensation
Quarter
Stock-Based Compensation
Q1 2026
$161M
Q4 2025
$136M
Q3 2025
$151M
Q2 2025
$185M
Q1 2025
$154M
Q4 2024
$142M
Q3 2024
$133M
Q2 2024
$211M
Q1 2024
$159M
Q4 2023
$121M
Q3 2023
$216M
Q2 2023
$162M
Source: LLY on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.